Eton Pharmaceuticals, Inc.
ETON
DELAYED 1 MONTH

2 insider filings · Latest: May 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 28, 2026May 29 8:16 PMBRYNJELSEN SEANDirector, President & CEO
Sale
120,000$31.88$3.8M833,694(D)

View →

May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
19,679$31.47$619.4K25,249(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
37,524$31.49$1.2M25,249(D)

View →

May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
42,797$33.39$1.4M25,249(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
19,679$3.58118,406(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
37,524$1.3812,476(D)

View →

May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
30,591$3.58125,609(D)

View →